RPTX — Repare Therapeutics, Inc.

Ownership history in MPM ASSET MANAGEMENT LLC  ·  22 quarters on record

This page tracks every 13F SEC filing in which MPM ASSET MANAGEMENT LLC reported a position in Repare Therapeutics, Inc. (RPTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
27.72% (2020 Q2)
Avg. % of fund
10.4%
First filed
2020 Q2
Last filed
2025 Q3
Quarters held
22
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 1,121,318 — 0% 4.43% $2.0M $1.76
2025 Q2 UNCHANGED 1,121,318 — 0% 3.60% $1.56B $1.39
2025 Q1 REDUCED 1,121,318 -562,389 -33.4% 1.59% $1.1M $0.99
2024 Q4 REDUCED 1,683,707 -558,929 -24.9% 1.77% $2.2M $1.31
18 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RPTX price (monthly, adj. close)

Other funds also holding RPTX

As of 2025 Q4 — sorted by position size

Rangeley Capital, LLC 2.78% BVF INC/IL 3Y 7Y 0.9% Blue Owl Capital Holdings LP 3Y 0.67% Redmile Group, LLC 3Y 7Y 0.3% Yakira Capital Management, Inc. 3Y 7Y 0.23% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 0.2% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 0.18% ORBIMED ADVISORS LLC 3Y 7Y 0.18% Militia Capital Partners, LP 0.12% FNY Investment Advisers, LLC 3Y 7Y 0.03%
← Back to MPM ASSET MANAGEMENT LLC Holdings